Essity AB (publ) Total Liabilities
Essity AB (publ) total liabilities. Based on the latest financial reports, Essity AB (publ) (ESSITY-B) has total liabilities worth Skr88.36 Billion SEK (≈ $9.51 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Essity AB (publ) (ESSITY-B) defensive interval to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Essity AB (publ) (2013–2025)
Total liabilities of Essity AB (publ) from 2013 to 2025. This chart illustrates how Essity AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Check ESSITY-B asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Essity AB (publ) Competitors by Total Liabilities
The table below lists competitors of Essity AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Coca-Cola FEMSA S.A.B. de C.V
F:CFSL
|
Germany | €186.25 Billion |
|
FedEx Freight Holding Company, Inc.
NYSE:FDXF
|
USA | $2.63 Billion |
|
Lennar Corporation
NYSE:LEN
|
USA | $12.29 Billion |
|
First Solar Inc
NASDAQ:FSLR
|
USA | $3.47 Billion |
|
Bunge Limited
NYSE:BG
|
USA | $27.11 Billion |
|
Viatris Inc
NASDAQ:VTRS
|
USA | $20.78 Billion |
|
CIMB Group Holdings Bhd
KLSE:1023
|
Malaysia | RM723.37 Billion |
|
PERNOD RIC. SA SP.ADR 1/5
F:PER0
|
Germany | €21.15 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Essity AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Essity AB (publ) balance sheet assets.
Liquidity & Leverage Metrics
Essity AB (publ) Total Liabilities Ratios Explained
Essity AB (publ) total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.95 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Essity AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Essity AB (publ) (2013–2025)
The table below shows the annual total liabilities of Essity AB (publ) from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr81.08 Billion ≈ $8.73 Billion |
-16.02% |
| 2024-12-31 | Skr96.54 Billion ≈ $10.39 Billion |
-21.88% |
| 2023-12-31 | Skr123.59 Billion ≈ $13.30 Billion |
-7.79% |
| 2022-12-31 | Skr134.04 Billion ≈ $14.42 Billion |
+25.80% |
| 2021-12-31 | Skr106.54 Billion ≈ $11.47 Billion |
+16.69% |
| 2020-12-31 | Skr91.30 Billion ≈ $9.83 Billion |
-8.23% |
| 2019-12-31 | Skr99.49 Billion ≈ $10.71 Billion |
+0.13% |
| 2018-12-31 | Skr99.37 Billion ≈ $10.69 Billion |
+1.97% |
| 2017-12-31 | Skr97.45 Billion ≈ $10.49 Billion |
+30.44% |
| 2016-12-31 | Skr74.70 Billion ≈ $8.04 Billion |
+11.37% |
| 2015-12-31 | Skr67.08 Billion ≈ $7.22 Billion |
-8.79% |
| 2014-12-31 | Skr73.54 Billion ≈ $7.91 Billion |
+6.51% |
| 2013-12-31 | Skr69.04 Billion ≈ $7.43 Billion |
-- |
About Essity AB (publ)
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutio… Read more